Dynavax's hep B vaccine meets main goals in late-stage study By: Reuters: Company News January 07, 2016 at 07:16 AM EST Jan 7 (Reuters) - Dynavax Technologies Corp said its experimental hepatitis B vaccine was found to be safe and effective in a late-stage study. Read More >> Related Stocks: Dynavax Technologies